Atractylodis Rhizoma-Atractylodis Macrocephala Rhizoma herbal pair restores intestinal mucosal barrier function in ulcerative colitis via activating Epac1/Rap1 pathway and inhibiting PI3K/AKT pathway
- 2 March 2026
- journal article
- Published by Elsevier in Chinese Journal of Natural Medicines
- Vol. 24 (3) , 313-325
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Rap1 in the Context of PCSK9, Atherosclerosis, and DiabetesCurrent Atherosclerosis Reports, 2023
- Ulcerative Colitis in AdultsJAMA, 2023
- Xianglian Pill attenuates ulcerative colitis through TLR4/MyD88/NF-κB signaling pathwayJournal of Ethnopharmacology, 2022
- Preventive effect of Atractylodis Rhizoma extract on DSS-induced acute ulcerative colitis through the regulation of the MAPK/NF-κB signals in vivo and in vitroJournal of Ethnopharmacology, 2022
- Protective effects of polysaccharides from Atractylodes macrocephalae Koidz. against dextran sulfate sodium induced intestinal mucosal injury on miceInternational Journal of Biological Macromolecules, 2022
- Atractylenolides (I, II, and III): a review of their pharmacology and pharmacokineticsArchives of Pharmacal Research, 2021
- Qingchang Huashi Formula attenuates DSS-induced colitis in mice by restoring gut microbiota-metabolism homeostasis and goblet cell functionJournal of Ethnopharmacology, 2021
- Deciphering the compatibility rules of traditional Chinese medicine prescriptions based on NMR metabolomics: A case study of XiaoyaosanJournal of Ethnopharmacology, 2020
- The Intestinal Epithelium: Central Coordinator of Mucosal ImmunityTrends in Immunology, 2018
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005